Paper Details

  1. Home
  2. Paper Details

Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM)

Author: AbrairaC, ColwellJ, ComstockJ, EmanueleN, HendersonW, LevinS, NuttallF, SawinC

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.

Overview

This study aimed to determine if an intensive treatment regimen could achieve a significant difference in HbA1c levels compared to standard therapy in type II diabetes patients.
Paper Details　
Original Abstract of the Article :
To determine, after 1 yr of follow-up in type II diabetes patients, whether a statistically and clinically significant difference can be achieved in HbA1c between a standard therapy group and an intensively treated group, while maintaining HbA1c levels in both groups within ranges acceptable in regu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2337/diacare.15.11.1560

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of Diabetes: Controlling Blood Sugar

Type II diabetes, like a relentless desert wind, challenges individuals to manage their blood sugar levels. This feasibility trial aims to evaluate the effectiveness of intensive treatment compared to standard therapy in controlling blood sugar in type II diabetes patients. Researchers aim to assess the impact of different treatment approaches on HbA1c levels, a marker of long-term blood sugar control. Their goal is to determine if intensive treatment can significantly improve HbA1c levels while maintaining safe and acceptable levels in both treatment groups.

Finding the Oasis: Effective Diabetes Management

This trial is like a search for an oasis in the desert of diabetes management. By meticulously analyzing the outcomes of both treatment approaches, researchers hope to identify the best strategy for achieving optimal blood sugar control. The study will focus on patient adherence to the protocol, potential side effects, and the accuracy of data collection, ensuring a comprehensive and reliable assessment of the treatment strategies.

Staying Hydrated: The Importance of Blood Sugar Control

The findings of this trial could provide valuable insights into the most effective way to manage type II diabetes. Just as staying hydrated is vital in the desert, maintaining stable blood sugar levels is crucial for preventing complications associated with diabetes. The results of this study may lead to improved treatment strategies for those living with type II diabetes, potentially reducing the burden of this chronic condition.

Dr.Camel's Conclusion

This feasibility trial aims to find the optimal strategy for managing type II diabetes, akin to discovering a life-giving oasis in the desert. By comparing intensive and standard treatment approaches, researchers seek to identify the most effective methods for achieving stable blood sugar levels and minimizing the risks associated with this chronic condition. This research offers hope for those navigating the challenges of diabetes, highlighting the importance of individualized treatment strategies and continued advancements in medical science.

Date :
  1. Date Completed 1993-01-28
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

1308130

DOI: Digital Object Identifier

10.2337/diacare.15.11.1560

Related Literature

Article Analysis
・Side Effects of glipizide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.